Detail akcie ResMed online

Business Summary: ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2024, Resmed Inc revenues increased 11% to $4.69B. Net income increased 14% to $1.02B. Revenues reflect Sleep and Respiratory Care segment increase of 10% to $4.1B, Software as a Service segment increase of 17% to $584.1M, United States segment increase of 10% to $2.98B, Rest of the world segment increase of 13% to $1.71B.